| Dr Hunter Russell Smith, MD | |
|
4820 Riverbend Rd Ste 100, Boulder, CO 80301-2618 | |
| (303) 415-5399 | |
| (303) 297-5808 |
| Full Name | Dr Hunter Russell Smith |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 44 Years |
| Location | 4820 Riverbend Rd Ste 100, Boulder, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174616130 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 24423 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Boulder Community Health | Boulder, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Boulder Community Health | 6800707233 | 212 |
News Archive
Orexigen® ( )Therapeutics, Inc today announced new data from the COR-I, COR-II and COR-Diabetes trials for Contrave® (bupropion SR/ naltrexone SR) to expand on top-line results announced in July. Contrave is the first of the Company's two late stage candidates for the treatment of obesity.
Johns Hopkins researchers report the discovery of a molecular switch that regulates the behavior of a protein that, when altered, is already known to increase human susceptibility to schizophrenia and mood disorders.
The Food and Drug Administration (FDA) has announced the licensing of a new vaccine against a disease responsible for tens of thousands of hospitalizations in the United States and hundreds of thousands of deaths around the world each year.
Extraversion does not just explain differences between how people act at social events. How extraverted you are may influence how the brain makes choices - specifically whether you choose an immediate or delayed reward, according to a new study. The work is part of a growing body of research on the vital role of understanding personality in society.
› Verified 4 days ago
| Entity Name | Boulder Community Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821074196 PECOS PAC ID: 6800707233 Enrollment ID: O20040123000284 |
News Archive
Orexigen® ( )Therapeutics, Inc today announced new data from the COR-I, COR-II and COR-Diabetes trials for Contrave® (bupropion SR/ naltrexone SR) to expand on top-line results announced in July. Contrave is the first of the Company's two late stage candidates for the treatment of obesity.
Johns Hopkins researchers report the discovery of a molecular switch that regulates the behavior of a protein that, when altered, is already known to increase human susceptibility to schizophrenia and mood disorders.
The Food and Drug Administration (FDA) has announced the licensing of a new vaccine against a disease responsible for tens of thousands of hospitalizations in the United States and hundreds of thousands of deaths around the world each year.
Extraversion does not just explain differences between how people act at social events. How extraverted you are may influence how the brain makes choices - specifically whether you choose an immediate or delayed reward, according to a new study. The work is part of a growing body of research on the vital role of understanding personality in society.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hunter Russell Smith, MD 5450 Western Ave, Boulder, CO 80301-2709 Ph: (303) 415-5399 | Dr Hunter Russell Smith, MD 4820 Riverbend Rd Ste 100, Boulder, CO 80301-2618 Ph: (303) 415-5399 |
News Archive
Orexigen® ( )Therapeutics, Inc today announced new data from the COR-I, COR-II and COR-Diabetes trials for Contrave® (bupropion SR/ naltrexone SR) to expand on top-line results announced in July. Contrave is the first of the Company's two late stage candidates for the treatment of obesity.
Johns Hopkins researchers report the discovery of a molecular switch that regulates the behavior of a protein that, when altered, is already known to increase human susceptibility to schizophrenia and mood disorders.
The Food and Drug Administration (FDA) has announced the licensing of a new vaccine against a disease responsible for tens of thousands of hospitalizations in the United States and hundreds of thousands of deaths around the world each year.
Extraversion does not just explain differences between how people act at social events. How extraverted you are may influence how the brain makes choices - specifically whether you choose an immediate or delayed reward, according to a new study. The work is part of a growing body of research on the vital role of understanding personality in society.
› Verified 4 days ago
Ms. Martha E Montour, RN Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 580 Mohawk Dr, Boulder, CO 80303 Phone: 303-440-2690 | |
Chester J Dreiman, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2562 Briarwood Dr, Boulder, CO 80305 Phone: 303-501-2195 | |
Pamela G Ingram, MSN Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 580 Mohawk Dr, Boulder, CO 80303 Phone: 303-554-5164 | |
Bradley D Fanestil, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4801 Riverbend Rd Ste 120b, Boulder, CO 80301 Phone: 303-415-8615 Fax: 303-293-0628 | |
Dr. Joseph Randall Lutt, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1840 Folsom St Ste 105, Boulder, CO 80302 Phone: 720-494-4706 Fax: 720-494-4706 | |
Dr. Amy O Campbell, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2880 Folsom St Ste 100, Boulder, CO 80304 Phone: 303-327-7047 Fax: 303-443-7168 | |
Wael F. Garas, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5495 Arapahoe Ave Ste 100, Boulder, CO 80303 Phone: 303-415-4250 Fax: 303-440-9629 |